Centiva Capital’s Akcea Therapeutics Inc AKCA Stock Holding History

Centiva Capital’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-50,000	Closed	-$907K	–	1206
2020 Q3	$907K	Buy	+50,000	New	+$709K	0.06%	217

Centiva Capital's AKCA Position: Q4 2020 in Review

Centiva Capital sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 50,000 shares — an estimated $907K sold.

Centiva Capital first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $907K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Centiva Capital reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Centiva Capital sold 50,000 Akcea Therapeutics Inc shares in Q4 2020, an estimated $907K.
Centiva Capital first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Centiva Capital's Akcea Therapeutics Inc position peaked at $907K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Centiva Capital's 13F filing for Q4 2020, filed 16 Feb 2021.